Glucosylsphingosine Is a Highly Sensitive and Specific Biomarker for Primary Diagnostic and Follow-Up Monitoring in Gaucher Disease in a Non-Jewish, Caucasian Cohort of Gaucher Disease Patients

• Arndt Rolfs ,

  * E-mail: arndt.rolfs@med.uni-rostock.de

  Affiliation Albrecht-Kossel-Institute for Neuroregeneration, University of Rostock, Rostock, Germany

  ⨯
• Anne-Katrin Giese,

  Affiliation Albrecht-Kossel-Institute for Neuroregeneration, University of Rostock, Rostock, Germany

  ⨯
• Ulrike Grittner,

  Affiliation Department for Biostatistics and Clinical Epidemiology, Charité-University Medical Centre, Berlin, Germany

  ⨯
• Daniel Mascher,

  Affiliation pharm-analyt Labor GmbH, Baden, Austria

  ⨯
• Deborah Elstein,

  Affiliation Gaucher Clinic, Shaare Zedek Medical Center, Jerusalem, Israel

  ⨯
• Ari Zimran,

  Affiliation Gaucher Clinic, Shaare Zedek Medical Center, Jerusalem, Israel

  ⨯
• Tobias Böttcher,

  Affiliation Albrecht-Kossel-Institute for Neuroregeneration, University of Rostock, Rostock, Germany

  ⨯
• Jan Lukas,

  Affiliation Albrecht-Kossel-Institute for Neuroregeneration, University of Rostock, Rostock, Germany

  ⨯
• Rayk Hübner,

  Affiliation Albrecht-Kossel-Institute for Neuroregeneration, University of Rostock, Rostock, Germany

  ⨯
• Uta Gölnitz,

  Affiliation Centogene GmbH, Rostock, Germany

  ⨯
• Anja Röhle,

  Affiliation Centogene GmbH, Rostock, Germany

  ⨯
• Ales Dudesek,

  Affiliation Department of Neurology, University of Rostock, Rostock, Germany

  ⨯
• Wolfgang Meyer,

  Affiliation Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London, United Kingdom

  ⨯
• Matthias Wittstock,

  Affiliation Department of Neurology, University of Rostock, Rostock, Germany

  ⨯
• Hermann Mascher

  Affiliation pharm-analyt Labor GmbH, Baden, Austria

  ⨯